Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes

Clinical and Vaccine Immunology

Volumn 17, Issue 6, 2010, Pages 1027-1033

  Sominskaya, Irina ^a   Skrastina, Dace ^a   Dislers, Andris ^a   Vasiljev, Denis ^a   Mihailova, Marija ^a   Ose, Velta ^a   Dreilina, Dzidra ^a   Pumpens, Paul ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C VACCINE; IMMUNOGLOBULIN;

AMINO TERMINAL SEQUENCE; ANTIGENICITY; ARTICLE; BAGG ALBINO MOUSE; CELL ACTIVATION; CHIMERA; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ESCHERICHIA COLI; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS PARTICLE;

ANIMALS; CYTOKINES; EPITOPES; FEMALE; HEPACIVIRUS; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL HEPATITIS VACCINES; VIRION;

EID: 77953148122     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00468-09     Document Type: Article

References (44)

1. Alekseeva, E., I. Sominskaya, D. Skrastina, I. Egorova, E. Starodubova, E. Kushners, M. Mihailova, N. Petrakova, R. Bruvere, T. Kozlovskaya, M. Isaguliants, and P. Pumpens. 2009. Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen. Genet. Vaccines Ther. 7:7.
2. Battegay, M., J. Fikes, A. M. Di Bisceglie, P. A. Wentworth, A. Sette, E. Celis, W. M. Ching, A. Grakoui, C. M. Rice, K. Kurokohchi, J. A. Berzofsky, J. H. Hoofnagle, S. M. Feinstone, and T. Akatsuka. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:2462-2470.
3. Bichko, V., F. Schodel, M. Nassal, E. Gren, I. Berzinsh, G. Borisova, S. Miska, D. L. Peterson, E. Gren, P. Pushko, and H. Will. 1993. Epitopes recognized by antibodies to denatured core protein of hepatitis B virus. Mol. Immunol. 30:221-231.
4. Blanchet, M., and C. Sureau. 2007. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J. Virol. 81:5841-5849.
5. Borisova, G., O. Borschukova, D. Skrastina, A. Dislers, V. Ose, P. Pumpens, and E. Grens. 1999. Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Biol. Chem. 380:315-324.
6. Borisova, G., M. Bundule, E. Grinstein, D. Dreilina, A. Dreimane, J. Kalis, T. Kozlovskaya, V. Loseva, V. Ose, P. Pumpen, P. Pushko, D. Snikere, E. Stankevica, V. Tsibinogin, and E. I. Gren. 1987. Recombinant capsid structures for exposure of protein antigenic epitopes. Mol. Gen. (Life Sci. Adv.) 6:169-174.
7. Carlos, M. P., Y. Yamamura, Q. Vu, K. Conzen, D. E. Anderson, and J. V. Torres. 2004. Humoral immunity to immunodominant epitopes of hepatitis C virus in individuals infected with genotypes 1a or 1b. Clin. Immunol. 111:22-27.
8. Chen, J. Y., and F. Li. 2006. Development of hepatitis C virus vaccine using hepatitis B core antigen as immuno-carrier. World J. Gastroenterol. 12:7774-7778.
9. Chen, X., M. Li, X. Le, W. Ma, and B. Zhou. 2004. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection. Vaccine 22:439-446.
10. Clarke, B. E., S. E. Newton, A. R. Carroll, M. J. Francis, G. Appleyard, A. D. Syred, P. E. Highfield, D. J. Rowlands, and F. Brown. 1987. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330:381-384.
11. Crowther, R. A., N. A. Kiselev, B. Bottcher, J. A. Berriman, G. P. Borisova, V. Ose, and P. Pumpens. 1994. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77:943-950.
12. Davis, G. L. 1999. Hepatitis C virus genotypes and quasispecies. Am. J. Med. 107:21S-26S.
13. Ferrari, C., A. Penna, A. Bertoletti, A. Cavalli, A. Valli, C. Schianchi, and F. Fiaccadori. 1989. The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J. Clin. Invest. 84:1314-1319.
14. Houghton, M., M. Selby, A. Weiner, and Q. L. Choo. 1994. Hepatitis C virus: structure, protein products and processing of the polyprotein precursor. Curr. Stud. Hematol. Blood Transfus. 61:1-11.
15. Jin, Y., W. K. Shih, and I. Berkower. 1988. Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J. Exp. Med. 168:293-306.
16. Kazaks, A., G. Borisova, S. Cvetkova, L. Kovalevska, V. Ose, I. Sominskaya, P. Pumpens, D. Skrastina, and A. Dislers. 2004. Mosaic hepatitis B virus core particles presenting the complete preS sequence of the viral envelope on their surface. J. Gen. Virol. 85:2665-2670.
17. Kim, J. H., J. H. Park, Y. J. Lee, E. W. Cho, Y. S. Bae, and K. L. Kim. 2000. In vitro binding analysis of hepatitis B virus preS-derived putative helper T-cell epitopes to MHC class II molecules using stable HLA-DRB1*0405/DRA*0101 transfected cells. IUBMB Life 50:379-384.
18. Lachmann, S., H. Meisel, C. Muselmann, D. Koletzki, H. R. Gelderblom, G. Borisova, D. H. Kruger, P. Pumpens, and R. Ulrich. 1999. Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope. Intervirology 42:51-56.
19. Lagging, L. M., K. Meyer, D. Hoft, M. Houghton, R. B. Belshe, and R. Ray. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:5859-5863.
20. Lo, M. C., A. Aulabaugh, G. Jin, R. Cowling, J. Bard, M. Malamas, and G. Ellestad. 2004. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal. Biochem. 332:153-159.
21. Mihailova, M., M. Boos, I. Petrovskis, V. Ose, D. Skrastina, M. Fiedler, I. Sominskaya, S. Ross, P. Pumpens, M. Roggendorf, and S. Viazov. 2006. Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV). Vaccine 24:4369-4377.
22. Mihailova, M., M. Fiedler, M. Boos, I. Petrovskis, I. Sominskaya, M. Roggendorf, S. Viazov, and P. Pumpens. 2006. Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity. Protein Expr. Purif. 50:43-48.
23. Neurath, A. R., S. B. Kent, K. Parker, A. M. Prince, N. Strick, B. Brotman, and P. Sproul. 1986. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine 4:35-37.
24. Newton, S. E., B. E. Clarke, G. Appleyard, M. J. Francis, A. R. Carroll, D. J. Rowlands, J. Skehel, and F. Brown. 1987. New approaches to FMDV antigen presentation using vaccinia virus, p. 12-21. In R. M. Chanock, R. A. Lerner, F. Brown, and H. Ginsberg (ed.), Modern approaches to new vaccines: prevention of AIDS and other viral, bacterial and parasitic diseases. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
25. Page, M., J.-L. Li, P. Pumpens, and G. Borisova. 15 March 2006. Modification of hepatitis B core antigen. European patent EP1294893.
26. Petit, M. A., S. Dubanchet, F. Capel, P. Voet, C. Dauguet, and P. Hauser. 1991. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47). Virology 180:483-491.
27. Pontisso, P., M. A. Petit, M. J. Bankowski, and M. E. Peeples. 1989. Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. J. Virol. 63:1981-1988.
28. Pumpen, P. P., A. V. Dishler, T. M. Kozlovskaia, V. V. Bychko, and E. I. Gren. 1981. Cloning of hepatitis B virus DNA in Escherichia coli. Dokl. Akad. Nauk SSSR. 260:1022-1024. (In Russian.)
29. Pumpens, P., and E. Grens. 2002. Artificial genes for chimeric virus-like particles, p. 249-327. In I. Khudiakov and H. A. Fields (ed.), Artificial DNA: methods and applications. CRC Press, Boca Raton, FL.
30. Pumpens, P., and E. Grens. 2001. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 44:98-114.
31. Pumpens, P., R. Ulrich, K. Sasnauskas, A. Kazaks, V. Ose, and E. Grens. 2008. Construction of novel vaccines on the basis of the virus-like particles: hepatitis B virus proteins as vaccine carriers, p. 205-248. In Y. E. Khudyakov (ed.), Medicinal protein engineering. CRC Press Taylor & Francis Group, Boca Raton, FL.
32. Riedl, P., D. Stober, C. Oehninger, K. Melber, J. Reimann, and R. Schirmbeck. 2002. Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain. J. Immunol. 168:4951-4959.
33. Sällberg, M., P. Pumpen, Z. X. Zhang, P. Lundholm, I. Gusars, U. Ruden, B. Wahren, and L. O. Magnius. 1994. Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein. J. Med. Virol. 43:62-68.
34. Schödel, F., A. M. Moriarty, D. L. Peterson, J. A. Zheng, J. L. Hughes, H. Will, D. J. Leturcq, J. S. McGee, and D. R. Milich. 1992. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J. Virol. 66:106-114.
35. Skrastina, D., A. Bulavaite, I. Sominskaya, L. Kovalevska, V. Ose, D. Priede, P. Pumpens, and K. Sasnauskas. 2008. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers. Vaccine 26:1972-1981.
36. Sominskaya, I., W. Paulij, J. Jansons, D. Sobotta, D. Dreilina, C. Sunnen, H. Meisel, W. H. Gerlich, and P. Pumpens. 2002. Fine-mapping of the B-cell epitope domain at the N-terminus of the preS2 region of the hepatitis B surface antigen. J. Immunol. Methods 260:251-261.
37. Sominskaya, I., P. Pushko, D. Dreilina, T. Kozlovskaya, and P. Pumpen. 1992. Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes. Med. Microbiol. Immunol. 181:215-226.
38. Sominskaya, I., D. Skrastina, E. Alekseeva, J. Jansons, and P. Pumpens. 2003. HBc-preS1 VLPs as potential vaccine candidates, abstr. 9-3-0007, p. 190. In A. McLachlan (ed.), Int. meeting of the molecular biology of hepatitis B viruses, 7 to 10 September 2003, Bergamo, Italy. [Abstract.]
39. Storni, T., F. Lechner, I. Erdmann, T. Bachi, A. Jegerlehner, T. Dumrese, T. M. Kundig, C. Ruedl, and M. F. Bachmann. 2002. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles. J. Immunol. 168:2880-2886.
40. Storni, T., C. Ruedl, K. Schwarz, R. A. Schwendener, W. A. Renner, and M. F. Bachmann. 2004. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J. Immunol. 172:1777-1785.
41. Tokushige, K., T. Wakita, C. Pachuk, D. Moradpour, D. B. Weiner, V. R. Zurawski, Jr., and J. R. Wands. 1996. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 24:14-20.
42. Weeratna, R. D., M. J. McCluskie, L. Comanita, T. Wu, and H. L. Davis. 2000. Optimization strategies for DNA vaccines. Intervirology 43:218-226.
43. Wynne, S. A., R. A. Crowther, and A. G. Leslie. 1999. The crystal structure of the human hepatitis B virus capsid. Mol. Cell 3:771-780.
44. Yang, H. J., M. Chen, T. Cheng, S. Z. He, S. W. Li, B. Q. Guan, Z. H. Zhu, Y. Gu, J. Zhang, and N. S. Xia. 2005. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus. World J. Gastroenterol. 11:492-497.